Ever Source Wealth Advisors, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 77 shares of CRNX stock, worth $4,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77
Previous 67
14.93%
Holding current value
$4,593
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRNX
# of Institutions
240Shares Held
79.5MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$375 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$372 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$351 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$295 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$266 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $3.21B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...